January 2025 PMID 39666366

In-Office Suprachoroidal Viscopexy for Acute Rhegmatogenous Retinal Detachment.

Rajeev H Muni, Isabela Martins Melo, Sueellen Demian, Tomas Minelli, Hatim Batawi, John Park, Aurora Pecaku

Mentions

12
Peak: 6 in Dec 2024
across 3 sources since Dec 2024

Extended reach

78,078
potential audience

Total likes

73

Video views

95

Mentions per month

Dec 2024 – Feb 2025

Where it's discussed

  • X / Twitter9 posts
  • YouTube2 videos
  • Bluesky1 posts

AI synopsis

What people are saying

The overall sentiment reflects strong agreement and high interest, with posts emphasizing the innovative, less invasive approach, such as 'requires no incisions' and 'promising technique.' The tone and context demonstrate enthusiasm and curiosity about the potential of SCVEXY to improve retinal detachment treatment, indicating a positive outlook on its future impact.

AgreementModerate agreement

Most discussions recognize the promise of the SCVEXY technique and support its potential benefits, indicating agreement with the publication's findings.

InterestHigh interest

Posts display high interest by highlighting the novelty, minimally-invasive nature, and positive initial outcomes, engaging readers in the topic.

EngagementModerate engagement

Posts reference specific procedural details and potential clinical advantages, showing moderate depth of engagement with the research.

ImpactModerate impact

Discussions emphasize the procedure's potential to influence ophthalmologic practice by offering an office-based, incision-free option, suggesting a moderate impact.

Abstract in brief

  • The in-office suprachoroidal viscopexy (SCVEXY) procedure shows promise for treating rhegmatogenous retinal detachment (RRD), with limited available data on its safety and effectiveness.
  • A study conducted at St Michael's Hospital from June 2023 to February 2024 followed 6 patients with primary acute RRD to measure outcomes post-SCVEXY treatment.
  • Results indicated that 83.3% of patients achieved anatomic reattachment, with no complications and the ability to return to normal activities shortly after the procedure.

Top posts

Most liked on X and Bluesky
JAMA Ophthalmology
@JAMAOphth · X

In-office suprachoroidal viscopexy (SCVEXY) shows promise as a novel technique for repairing primary acute rhegmatogenous retinal detachment without the need for incisional surgery, intraocular tamponade, or postoperative positioning. https://t.co/HZHyBBuZPZ https://t.co/mu1fRhNvTa

Dec 12, 2024 · 30 likes · 6 shares · 20,822 followers View post →
JAMA Ophthalmology
@JAMAOphth · X

In-office suprachoroidal viscopexy (SCVEXY) shows promise as a novel technique for repairing primary acute rhegmatogenous retinal detachment without the need for incisional surgery, intraocular tamponade, or postoperative positioning. https://t.co/fbaZ7Qgm1k https://t.co/vTVJsHzW0c

Feb 3, 2025 · 23 likes · 7 shares · 20,822 followers View post →
Takashi Nishida
@tnishida_ · X

#眼科文献 上脈絡膜腔への粘弾性物質の注射によって網膜下液を引かせて網膜剥離の治療を行うという手法による症例シリーズ。 https://t.co/5TsV9OlzWk

Dec 12, 2024 · 13 likes · 1 share · 343 followers View post →
Unity Health Toronto
@UnityHealthTO · X

A St. Michael’s Hospital team that's developed a minimally-invasive technique to repair retinal detachment has published the results of 6 patient cases. The technique, called SCVEXY, requires no incisions and can be performed in office: https://t.co/Pawo1UDhUt

Dec 12, 2024 · 4 likes · 1 share · 32,262 followers View post →
robert{公式}
@76froberto · X

RT @tnishida_: #眼科文献 上脈絡膜腔への粘弾性物質の注射によって網膜下液を引かせて網膜剥離の治療を行うという手法による症例シリーズ。 https://t.co/5TsV9OlzWk

Dec 26, 2024 · 1 share · 2,922 followers View post →
Rosa M. Coco
@roscoma1966 · X

RT @JAMAOphth: In-office suprachoroidal viscopexy (SCVEXY) shows promise as a novel technique for repairing primary acute rhegmatogenous re…

Dec 12, 2024 · 6 shares · 527 followers View post →

All mentions

DrAyman1982
@DrAyman1982 · X

RT @JAMAOphth: In-office suprachoroidal viscopexy (SCVEXY) shows promise as a novel technique for repairing primary acute rhegmatogenous re…

Feb 3, 2025 · 7 shares · 18 followers View post →
mahjabeen choudhury
@echopushpa · X

RT @JAMAOphth: In-office suprachoroidal viscopexy (SCVEXY) shows promise as a novel technique for repairing primary acute rhegmatogenous re…

Feb 3, 2025 · 7 shares · 139 followers View post →
JAMA Ophthalmology
@JAMAOphth · X

In-office suprachoroidal viscopexy (SCVEXY) shows promise as a novel technique for repairing primary acute rhegmatogenous retinal detachment without the need for incisional surgery, intraocular tamponade, or postoperative positioning. https://t.co/fbaZ7Qgm1k https://t.co/vTVJsHzW0c

Feb 3, 2025 · 23 likes · 7 shares · 20,822 followers View post →
Ophthopedia
@ophthalmology.bsky.social · Bluesky

Ophthopedia Update: In-Office Suprachoroidal Viscopexy for Acute Rhegmatogenous Retinal Detachment: This case series study of 6 patients treated at a single center in Canada reports outcomes with in-office suprachoroidal viscopexy for primary acute rhegmatogenous… #Ophthalmology #Eyecare #JAMA

Jan 16, 2025 View post →
robert{公式}
@76froberto · X

RT @tnishida_: #眼科文献 上脈絡膜腔への粘弾性物質の注射によって網膜下液を引かせて網膜剥離の治療を行うという手法による症例シリーズ。 https://t.co/5TsV9OlzWk

Dec 26, 2024 · 1 share · 2,922 followers View post →
Takashi Nishida
@tnishida_ · X

#眼科文献 上脈絡膜腔への粘弾性物質の注射によって網膜下液を引かせて網膜剥離の治療を行うという手法による症例シリーズ。 https://t.co/5TsV9OlzWk

Dec 12, 2024 · 13 likes · 1 share · 343 followers View post →
Maria Guajardo
@MariaGuajardo11 · X

RT @JAMAOphth: In-office suprachoroidal viscopexy (SCVEXY) shows promise as a novel technique for repairing primary acute rhegmatogenous re…

Dec 12, 2024 · 6 shares · 45 followers View post →
Rosa M. Coco
@roscoma1966 · X

RT @JAMAOphth: In-office suprachoroidal viscopexy (SCVEXY) shows promise as a novel technique for repairing primary acute rhegmatogenous re…

Dec 12, 2024 · 6 shares · 527 followers View post →
Unity Health Toronto
@UnityHealthTO · X

A St. Michael’s Hospital team that's developed a minimally-invasive technique to repair retinal detachment has published the results of 6 patient cases. The technique, called SCVEXY, requires no incisions and can be performed in office: https://t.co/Pawo1UDhUt

Dec 12, 2024 · 4 likes · 1 share · 32,262 followers View post →
JAMA Ophthalmology
@JAMAOphth · X

In-office suprachoroidal viscopexy (SCVEXY) shows promise as a novel technique for repairing primary acute rhegmatogenous retinal detachment without the need for incisional surgery, intraocular tamponade, or postoperative positioning. https://t.co/HZHyBBuZPZ https://t.co/mu1fRhNvTa

Dec 12, 2024 · 30 likes · 6 shares · 20,822 followers View post →